Disease-A-Month
Volume 55, Issue 11 , Pages 649-660 , November 2009

Sarcoidosis: Epidemiology, Etiology, Pathogenesis, and Genetics

References 

  1. Sharma O. Sarcoidosis: A historical perspective. Clin Dermatol. 2007;25:232–241
  2. Statement on Sarcoidosis (Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999). Am J Respir Crit Care Med. 1999;160:736–755
  3. Rybicki BA, Major M, Popovich J, et al. Racial differences in sarcoidosis incidence: A 5-year study in a health maintenance organization. Am J Epidemiol. 1997;145:234–241
  4. Chen ES, Moller DR. Etiology of sarcoidosis. Clin Chest Med. 2008;29:365–377
  5. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007;357:2153–2165
  6. Nagai S, Izumi T. Pulmonary sarcoidosis: Population differences and pathophysiology. South Med J. 1995;88:1001–1010
  7. Milman N, Selroos O. Pulmonary sarcoidosis in the Nordic countries 1950-1981: Epidemiology and clinical picture. Sarcoidosis. 1990;7:50–57
  8. Milman N, Hoffmann AL. Childhood sarcoidosis: Long-term follow up. Eur Respir J. 2008;31:592–598
  9. Fauroux B, Clément A. Pediatric sarcoidosis. Pædiatr Respir Rev. 2005;6:128–133
  10. Sharma OP. Sarcoidosis around the world. Clin Chest Med. 2008;29:357–363
  11. Iwai K, Sekiguti M, Hosoda Y, et al. Racial difference in cardiac sarcoidosis observed at autopsy. Sarcoidosis. 1994;11:26–31
  12. Sharma SK, Mohan A. Sarcoidosis: Global scenario and Indian perspective. Indian J Med Res. 2002;116:221–247
  13. Newman LS, Rose CS, Bresnitz EA, et al. A case control etiologic study of sarcoidosis: Environmental and occupational risk factors. Am J Respir Crit Care Med. 2004;170:1324–1330
  14. Barnard J, Rose C, Newman L, et al. Job and industry classifications associated with sarcoidosis in a case control etiologic study of sarcoidosis (ACCESS). J Occup Environ Med. 2005;47:226–234
  15. Song Z, Marzilli L, Greenlee BM, et al. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoid. J Exp Med. 2005;201:721–767[Published erratum in J Exp Med 2005;202:72]
  16. Drake WP, Dhason MS, Nadaf M, et al. Cellular recognition of Mycobacterium tuberculosis ESAT-6 and KatG peptides in systemic sarcoidosis. Infect Immun. 2007;75:527–530
  17. Klemen H, Husain AN, Cagle PT, et al. Mycobacterial DNA in recurrent sarcoidosis in the transplanted lung: A PCR-based study on four cases. Virchows Arch. 2000;436:365–369
  18. Gupta D, Agarwal R, Agarwal AN, et al. Molecular evidence for the role of mycobacteria in sarcoidosis: A meta-analysis. Eur Respir J. 2007;30:508–516
  19. Eishi Y, Suga M, Ishige I, et al. Quantitative analysis of mycobacterial and propionibacterial DNA in lymphnodes of Japanese and European patients with sarcoidosis. J Clin Microbiol. 2002;40:198–204
  20. Hiramatsu J, Kataoka M, Nakata Y, et al. Propionibacterium acnes DNA detected in bronchoalveolar lavage cells from patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2003;20:197–203
  21. Bachelez H, Senet P, Cadranel J, et al. The use of tetracyclines for the treatment of sarcoidosis. Arch Dermatol. 2001;137:69–73
  22. Ishige I, Eishi Y, Takemura T, et al. Propionibacterium acnes is the most common bacterium commensal in peripheral lung tissue and mediastinal lymph nodes from subjects without sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2005;22:33–42
  23. Heyll A, Meckenstock G, Aul C, et al. Possible transmission of sarcoidosis via allogenic bone marrow transplantation. Bone Marrow Transplant. 1994;14:161–164
  24. Izbicki G, Chavko R, Banauch GI, et al. World Trade Center “sarcoid-like” granulomatous pulmonary disease in New York City Fire Department rescue workers. Chest. 2007;131:1414–1423
  25. Ma Y, Gal A, Koss MN. The pathology of pulmonary sarcoidosis: Update. Semin Diagn Pathol. 2007;24:150–161
  26. Gerke AK, Hunninghake G. The immunology of sarcoidosis. Clin Chest Med. 2008;29:379–390
  27. Hunninghake GW, Gadek JE, Young RC, et al. Maintenance of granuloma formation in pulmonary sarcoidosis by T-lymphocytes within the lung. N Engl J Med. 1980;302:594–598
  28. Agostini C, Adami F, Semenzato G. New pathogenetic insights into the sarcoid granuloma. Curr Opin Rheumatol. 2000;12:71–76
  29. Grunewald J, Eklund A. Role of CD4+ T cells in sarcoidosis. Proc Am Thorac Soc. 2007;4:461–462
  30. Moller DR, Forman JD, Liu MC, et al. Enhanced expression of IL-12 associated Th1 cytokine profiles in active pulmonary sarcoidosis. J Immunol. 1996;156:4952–4960
  31. Girgis RE, Basha MA, Maliaril M, et al. Cytokines in the bronchoalveolar lavage fluid of patients with active pulmonary sarcoidosis. Am J Respir Crit Care Med. 1995;152:71
  32. Shigehara K, Shijubo N, Ohmichi M, et al. IL-12 and IL-18 are increased and stimulate IFN-gamma production in sarcoid lungs. J Immunol. 2001;166:642–649
  33. Mathew S, Bauer KL, Fischoeder A, et al. The anergic state in sarcoidosis is associated with diminished dendritic cell function. J Immunol. 2008;181:746–755
  34. Siltzback LE. The Kveim test in sarcoidosis: A study of 750 patients. J Am Med Assoc. 1961;178:476–482
  35. Judson MA, Hirst K, Iyengar SK, et al. Comparison of sarcoidosis phenotypes among affected African-American siblings. Chest. 2006;130:855–862
  36. Grunewald J, Ekland A, Olerup O. Human leukocyte antigen class I alleles and the disease course in sarcoidosis patients. Am J Respir Crit Care Med. 2004;169:696–702
  37. Martinetti M, Tinelli C, Kolek V, et al. “The sarcoidosis map”: A joint survey of clinical and immunogenetic findings in two European countries. Am J Respir Crit Care Med. 1995;152:557–564
  38. Iannuzzi MJ, Maliarik MJ, Poisson LM, et al. Sarcoidosis susceptibility and resistance HLA-DQB1 alleles in African Americans. Am J Respir Crit Care Med. 2003;167:1225–1231
  39. Rossman MD, Thompson B, Frederick M, et al. HLA-DRB* 1101: A significant factor for sarcoidosis in blacks and whites. Am J Hum Genet. 2003;73:720–735
  40. Rybicki BA, Maliarik MJ, Poisson LM, et al. The major histocompatibility complex gene region and sarcoidosis susceptibility in African Americans. Am J Respir Crit Care Med. 2003;167:444–449
  41. Rutherford RM, Brutsche MH, Kearns M, et al. HLA-DR2 predicts susceptibility and disease chronicity in Irish sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis. 2004;21:191–198
  42. Iannuzzi MC, Rybicki BA. Genetics of sarcoidosis. Proc Am Thorac Soc. 2007;4:108–116
  43. Schürmann M, Reichel P, Müller-Myhsok B, et al. Results from a genome-wide search for predisposing genes in sarcoidosis. Am J Respir Crit Care Med. 2001;164:840–846
  44. Iannuzzi MC, Iyengar SK, Gray-McGuire C, et al. Genome-wide search for sarcoidosis susceptibility genes in African Americans. Genes Immun. 2005;6:509–518
  45. Müller-Quernheim J, Schürmann M, Hofmann S, et al. Genetics of sarcoidosis. Clin Chest Med. 2008;29:391–414
  46. Gray-McGuire C, Sinha R, Iyengar SK, et al. Genetic characterization and fine mapping of susceptibility loci for sarcoidosis in African Americans on chromosome 5. Hum Genet. 2006;120:420–430
  47. Grunewald J, Eklund A. Löfgren's syndrome: human leukocyte antigen strongly influences the disease course. Am J Respir Crit Care Med. 2009;179:307–312

 Competing interestsNo financial or other potential conflicts of interest exist for the above author. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Army, Department of Defense, or the U.S. Government.

PII: S0011-5029(09)00055-8

doi: 10.1016/j.disamonth.2009.04.008

Disease-A-Month
Volume 55, Issue 11 , Pages 649-660 , November 2009

Article Tools